151 related articles for article (PubMed ID: 2411820)
1. Radioimmunoassay of cholecystokinin: comparison of different tracers.
Cantor P; Rehfeld JF
J Immunol Methods; 1985 Sep; 82(1):47-55. PubMed ID: 2411820
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels.
Jansen JB; Lamers CB
J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of a new labeled gastrin ligand, 125-I-BH-[Leu15]-gastrin-(5-17), on binding to canine fundic mucosal cells and Jurkat cells.
Galleyrand JC; Lima-Leite AC; Lallement JC; Lignon MF; Bernad N; Fulcrand P; Martinez J
Int J Pept Protein Res; 1994 Oct; 44(4):348-56. PubMed ID: 7875937
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
6. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
Lallement JC; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1994 May; 267(3):297-305. PubMed ID: 8088368
[TBL] [Abstract][Full Text] [Related]
7. Low binding of Bolton-Hunter-labelled cholecystokinin-33 to carboxyl-terminal CCK-antibodies.
Jansen JB; Lamers CB
J Immunol Methods; 1982 Jun; 51(2):223-30. PubMed ID: 6286777
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
Lin CW; Miller T
J Pharmacol Exp Ther; 1985 Mar; 232(3):775-80. PubMed ID: 2983069
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
Lallement JC; Oiry C; Lima-Leite AC; Lignon MF; Fulcrand P; Galleyrand JC; Martinez J
Eur J Pharmacol; 1995 Jul; 290(2):61-7. PubMed ID: 8575534
[TBL] [Abstract][Full Text] [Related]
11. Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays.
Jansen JB; Hopman WP; Lamers CB
Dig Dis Sci; 1984 Dec; 29(12):1109-17. PubMed ID: 6499629
[TBL] [Abstract][Full Text] [Related]
12. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
13. High affinity binding of cholecystokinin to small cell lung cancer cells.
Yoder DG; Moody TW
Peptides; 1987; 8(1):103-7. PubMed ID: 3033616
[TBL] [Abstract][Full Text] [Related]
14. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
15. Accurate measurement of cholecystokinin in plasma.
Rehfeld JF
Clin Chem; 1998 May; 44(5):991-1001. PubMed ID: 9590372
[TBL] [Abstract][Full Text] [Related]
16. Preparation of biologically active radioiodinated cholecystokinin for radioreceptor assay and radioimmunoassay.
Sankaran H; Deveney CW; Goldfine ID; Williams JA
J Biol Chem; 1979 Oct; 254(19):9349-51. PubMed ID: 226515
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of cholecystokinin in human tissue and plasma.
Jansen JB; Lamers CB
Clin Chim Acta; 1983 Jul; 131(3):305-16. PubMed ID: 6883724
[TBL] [Abstract][Full Text] [Related]
18. Gastrin/cholecystokinin-like immunoreactive peptides in the Dungeness crab, Cancer magister (Dana): immunochemical and biological characterization.
Larson BA; Vigna SR
Regul Pept; 1983 Oct; 7(2):155-70. PubMed ID: 6197724
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cholecystokinin receptors on the sphincter of Oddi.
Cox KL; von Schrenck T; Moran TH; Gardner JD; Jensen RT
Am J Physiol; 1990 Nov; 259(5 Pt 1):G873-81. PubMed ID: 2240227
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay of cholecystokinin-pancreozymin.
Harvey RF; Dowsett L; Hartog M; Read AE
Gut; 1974 Sep; 15(9):690-9. PubMed ID: 4435583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
